Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1327 of 6351
-
Could a breathing app and exercise team up to beat high blood pressure?
Disease control Not yet recruitingHypertension is a major risk factor for cardiovascular disease and is associated with reduced functional capacity and impaired quality of life. Non-pharmacological interventions, including aerobic exercise and paced breathing, may improve blood pressure control by enhancing cardi…
Sponsor: Cairo University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can surgery restore a burned Hand's full reach?
Disease control Not yet recruitingassess and compare the functional and aesthetic outcomes of different surgical techniques used for reconstruction of post-traumatic and post-burn first web space obliteration.
Sponsor: Sohag University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Experimental combo aims to tackle Treatment-Resistant cancers
Disease control Not yet recruitingThe purpose of this first-in-human study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of TLN-499 in combination with venetoclax in participants with relapsed/refractory solid tumors.
Phase 1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New speech therapy approach may help children with cleft palate speak more clearly
Disease control By invitation onlyCleft Palate ± Lip (CP±L) is one of the most well-known congenital anomalies worldwide. Children and adolescences with CP±L are at high risk of developing speech and communication difficulties due to a range of cleft-related etiologies. Even with timely or early repair of the pal…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can big data unlock the secrets of opening blocked heart arteries?
Knowledge-focused Not yet recruitingThe TURK CTO Registry is a prospective, multicenter, observational registry designed to evaluate the contemporary management and outcomes of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) in Türkiye. The registry will include consecutive adult patient…
Sponsor: Ahmet Seyfeddin Gürbüz • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can insulin help heal gums? a trial puts it to the test
Disease control Recruiting nowThe present study will be performed on fourty-five patients suffering from periodontitis according to the criteria of American academy of periodontology to evaluate clinically effect of topical application of insulin versus hyaluronic acid as an adjunct to non surgical periodonta…
Early phase 1 • Sponsor: Doaa Atta Aid • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a lighter sedative dose keep patients calm after nasal surgery?
Symptom relief Not yet recruitingEmergence agitation (EA) is a common complication during recovery from sevoflurane anesthesia, particularly after nasal surgery. Although remimazolam 0.1 mg/kg has been shown to reduce the incidence of EA, this dose may produce excessive sedation and increase the risk of intraope…
Phase 4 • Sponsor: Jeju National University School of Medicine • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Can a new iron injection match the standard treatment?
Disease control Recruiting nowThe goal of this clinical trial is to compare the pharmacokinetic profile of the developed drug product and reference product in participants with iron deficiency anemia under fasting condition. The main questions it aims to answer are: * \[Question 1\] Is there significant diff…
Phase 1 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Acupuncture and exercise join forces against chemotherapy nerve pain
Symptom relief Recruiting nowChemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatment that causes numbness, pain, and balance issues in a patient's hands and feet. This study focuses on finding a non-drug approach to help cancer survivors manage these uncomfortable sympto…
Sponsor: Show Chwan Memorial Hospital • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Can a simple relaxation technique soothe the mind after a stroke?
Symptom relief Not yet recruitingThis study tests whether Benson Relaxation Technique (BRT), a simple mind-body relaxation method, can help reduce anxiety and depression in patients who had an ischemic stroke 7-14 days ago. Patients will be randomly assigned to either the BRT group (receiving 20-minute relaxatio…
Sponsor: Geng Nannan • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
New hope for kids with liver fluke: drug trial launches
Disease control Recruiting nowThis study aims to assess the efficacy, safety and acceptability of ascending doses of arpraziquantel in children infected with Opisthorchis viverrini. The primary objective is to determine the dose-response relationship in terms of cure rate. This study will involve children age…
Phase 2 • Sponsor: Jennifer Keiser • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Timing tooth extractions could speed up braces treatment
Disease control Recruiting nowThe goal of this randomized controlled trial is to evaluate whether the timing of premolar extraction affects the rate of orthodontic space closure during en-masse anterior retraction. The study will also assess gingival cleft formation, mesial movement of the upper first molars,…
Sponsor: Shifa College of Dentistry • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Exercise may boost immunotherapy in kidney cancer
Disease control Recruiting nowThe primary aim of this study is to evaluate the feasibility of a supervised high intensity interval training (HIIT) program during first-line dual immune checkpoint inhibitor (ICI) therapy (nivolumab plus ipilimumab) in patients with advanced renal cell carcinoma (RCC). The seco…
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a feeding tube after transplant save the gut?
Disease control Recruiting nowThis is a randomized controlled phase II trial which will enroll 112 patients with a diagnosis of a blood cancer or a serious blood disorder who plan to undergo an allogenic hematopoietic stem cell transplant using any conditioning regimen or graft source. Eligible patients will …
Phase 2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
One pill, many questions: could emergency contraception briefly alter blood vessel health?
Knowledge-focused Recruiting nowThe goal of this double-blind randomized controlled trial is to learn about the impacts of a single dose of Plan B® on the cardiovascular system in young, health, premenopausal females. The main questions it aims to answer are: 1. What is the short-term affect of Plan B® affect …
Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Sleep hormone melatonin put to the test against lupus fatigue and inflammation
Symptom relief Not yet recruitingThe aim of the current study is to evaluate the effect of melatonin administration on circulating levels of inflammatory mediators, oxidative stress, sleep quality, fatigue and quality of life in patients with SLE. To the best of our knowledge, this is the first randomized-contro…
Phase 2/3 • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Can patients stop Anti-Rejection drugs sooner after transplant?
Disease control Recruiting nowThe purpose of this study is to test the feasibility and safety of early cessation of tacrolimus following allogeneic hematopoietic cell transplantation (HCT). Post-HCT tacrolimus is given to prevent graft-vs-host-disease (GVHD), but with the use of post-transplant cyclophosphami…
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Hope for kids with scarred lungs: new drug trial launches
Disease control Recruiting nowThis study is open to children and adolescents aged 2 to 17 years with interstitial lung disease (ILD). Nerandomilast has just been approved in some countries to help adults with a lung condition called idiopathic pulmonary fibrosis. The purpose of this study is to understand how…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for kids with rare Muscle-Weakening disease: drug trial launches
Disease control Recruiting nowThe primary objectives of this study are to characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of inebilizumab administered in pediatric participants with gMG, and to assess the safety and tolerability of inebilizumab administered in pediatric participants with gMG.
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Which nerve block offers better pain control for dialysis access surgery?
Symptom relief By invitation onlyThis study aims to determine whether ultrasound guided ESP block at 2nd thoracic vertebrae is non inferior to ultrasound guided ICBN block as adjunct to supraclavicular brachial plexus block in achieving complete sensory blockade of the medial upper arm during AVF superficializat…
Sponsor: Fatma Hatem Mokhtar • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC